Ki-67, a marker of proliferation;Ki-67, marqueur de proliferation

Annales de Pathologie

Volumn 17, Issue 1, 1997, Pages 25-30

  Guinebretiere J M ^a   Sabourin, J C ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

cellular cycle; Ki 67 antibody; mitotic rate; proliferation rate

Indexed keywords

CYCLINE; MONOCLONAL ANTIBODY KI 67; KI 67 ANTIGEN; MONOCLONAL ANTIBODY; TUMOR MARKER;

CELL CYCLE; CELL PROLIFERATION; CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; REVIEW; TECHNIQUE; CELL DIVISION; IMMUNOLOGY;

ANTIBODIES, MONOCLONAL; CELL CYCLE; CELL DIVISION; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; TUMOR MARKERS, BIOLOGICAL;

EID: 0031090451     PISSN: 02426498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. BLOOM H. RICHARDSON W. Histological grading and prognosis in breast cancer. Br J Cancer 1957 ; 11 : 359-77.
2. CONTESSO G, MOURIESSE H, FRIEDMAN S, GÉNIN J, SARRAZIN D, ROUESSÉ J. The importance of histologic grade in long-term prognosis of breast cancer: a study of 1010 patients uniformly treated at the Institut Gustave Roussy. J Clin Oncol 1986 ; 5 : 1378-86.
3. TROJANI M, CONTESSO G, COINDRE JM, ROUESSE J, BUI NB, DE MASCAREL A et al. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 1984 ; 33 : 37-42.
4. TUBIANA M, PEJOVIC M, CHAVAUDRA G, CONTESSO G, MALAISE E. The long-term prognosis significance of the thymidine labeling index in breast cancer. Int J Cancer 1984 ; 33 : 441-5.
5. GERDES J, SCHWAB U, LEMKE H, STEIN H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983 ; 31 : 13-20.
6. HALL P, MAC KEE P, Du P MENAGE H, DOVER R, DP. L. High levels of p53 protein in UV-irradiated normal human skin. Oncogene 1993 ; 8 : 203-8.
7. HITCHCOCK C. Ki-67 staining as a mean to simplify analysis of tumor cell proliferation. Am J Clin Pathol 1991 ; 96 : 444-5.
8. GERDES J, BECKES MHG, KEY G, CATTORETTI G. Immunohistological detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues. J Pathol 1992 ; 168 : 85-7.
9. GERDES J, LI L, SCHLUETER C, DUCHROW M, WOLHENBERG C, GERLACH C et al. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by the monoclonal antibody Ki67. Am J Pathol 1991 ; 138 : 867-3.
10. KUBBUTAT M, KEY G, DUCHROW M, SCHLÜTER C, FLAD H, GERDES J. Epitope analysis of antibodies recognizing the cell proliferation associated nuclear antigen previously defined by the antibody Ki-67 (Ki-67 protein). J Clin Pathol 1994 ; 47 : 524-8.
11. BRUNO S, DAZYNKIEWICZ Z. Cell cycle dependent expression and stability of the nuclear antigen detected by Ki67 antibody in HL-60 cells. Cell Prolif 1992 ; 25 : 31-40.
12. CHEVALLIER P. PEST sites in nuclear proteins. Int J Biochem 1993 ; 25 : 479-82.
13. VAN DIERENDONCK JH, KEIJZER R, VAN DE VELDE CJH, CORNELISSE CJ. Nuclear distribution of the Ki-67 antigen during the cell cycle: comparison with growth fraction in human breast cancer cells. Cancer Res 1989 ; 49 : 2999-3006.
14. SAWHNEY N, HALL P. Ki67-structure. function, and new antibodies. J Pathol 1992 ; 168 : 161-2.
15. Ross W, HALL P. Ki67: from antibody to molecule understanding? J Clin Pathol : Mol Pathol 1995 ; 48 : M1113-7.
16. KEY G, BECKER MH, BARON B, DUCHROW M, SCHLÜTER C, FLAD HD et al. New Ki67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki67 cDNA containing three 62 base pair repetitive elements encoding for the Ki7 epitope. Lab Invest 1993 ; 68 : 629-36.
17. REYNOLDS G, ROWLANDS D, MEAD G. Detection of Ki67 antigen by a new sheep polyclonal antiserum. J Clin Pathol 1995 ; 48 : 1138-40.
18. KEY G, PETERSEN J, BECKER M, DUCHROW M, SCHLÜTER C, ASKAA J et al. New antiserum against Ki-67 antigen suitable for double immunostaining of paraffin wax sections. J Clin Pathol 1993 ; 46 : 1080-4.
19. LEONG A, VINYUVAT S, SUTHIPINTAWONG C, MILIOS J. A comparison study of cell proliferation markers in breast carcinomas. J Clin Pathol : Mol Pathol 1995 ; 48 : M83-7.
20. BARBARESHI M, GIRLANDO S, MAURI F, FORTI S, C. E, MAURI F et al. Quantitative growth fraction evaluation with MIB1 and Ki67 antibodies in breast carcinomas. Am J Clin Pathol 1994 ; 102 : 171-5.
21. TORP S, JOHANNESEN E, LINDBOE C. Comparison of different Ki67 antibodies in human glioablastomas. J Clin Pathol : Mol Pathol 1995 ; 48 : M191-3.
22. KREIPE H, HEIDEBRECHT J, HANSEN S, RöHLK W, KUBBIES M, WACKER H et al. A new proliferation-associated nuclear antigen detectable in paraffin-embedded tissues by the monoclonal antibody Ki-S1. Am J Pathol 1993 ; 142 : 3-10.
23. CAMPLEJOHN RS, BROCK A, BARNES D, GILLET C, RAIKUNDALIA B, KREIPE et al. Ki-S1, a novel proliferative marker: flow cytometric assesment of staining in human breast carcinoma cells. Br J Cancer 1993 ; 67 : 657-62
24. CATTORETTI G, BECKER M, KEY G, DUCHROW M, SCHLUTER C, GALLE J et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin fixed paraffin sections. J Pathol 1992 ; 168 : 357-63.
25. HAERLEV T, JACOBSEN GK, ZEDELER K. Correlation of growth fraction by Ki-67 and proliferating cell nuclear antigen (PCNA) immunohistochemistry with histopathological parameters and prognosis in primary breast carcinomas. Breast Cancer Res Treat 1996 ; 36 : 101-13.
26. SHI S, KEY M, KALRA K. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem. 1991 ; 39 : 741-8.
27. CUEVAS E, BATEMAN A, WILKINS B, JOHNSON P, WILLIAMS J, LEE A et al. Microwave antigen retrieval in immunocytochemistry: a study of 80 antibodies. J Clin Pathol 1994 ; 47 : 448-52.
28. TAYLOR C, SHAN-RONG S, CHAIWUN B, YOUNG L, IMAM I, COTE R. Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections. Hum Pathol 1994 ; 25 : 263-70.
29. Mc CORMICK D, YU C, HOBBS C, HALL P. The relevance of antibody concentration to the immunohistological quantification of cell proliferation-associated antigens. Histopathology 1993 ; 22 : 543-7.
30. SAHIN A, RO J, EL-NAGGAR A, WILSON P, TEAGUE K, BLICK M et al. Tumor proliferative fraction in solid malignant neoplasms. A comparative study of Ki-67 immunostaining and flow cytometric determinations. Am J Clin Pathol 1991 ; 96 : 512-9.
31. VERONESE S, GAMBACORTA M, GOTTARDI O, SCANZI F, FERRARI M, LAMPERTICO P. Proliferation index as a prognostic marker in breast cancer. Cancer 1993 ; 71 : 3926-31.
32. GEE J, DOUGLAS-JONES A, HEPBURN P, SHARMA A, MAC CLELLAND R, ELLIS I et al. A cautionary note regarding the application of Ki-67 antibodies to paraffin -embedded breast cancers. J Pathol 1995 ; 177 : 285-93.
33. CHARPIN C, ANDRAC L, VACHERET H, HABIB M, DEVICTOR B, LAVAUT M et al. Multiparametric evaluation (SAMBA) of growth fraction (monoclonal Ki67) in breast carcinoma tissue sections. Cancer Res 1988 ; 48 : 4368-74.
34. SCHWARTZ B, PINKUS G, BACUS S, TODER M, WEINBERG D. Cell proliferation in non-Hodgkin's lymphomas. Digital image analysis of Ki-67 antibody staining. Am J Pathol 1989 ; 134 : 327-36.
35. GASPARINI G, POZZA F, BEVILACQUA P, MELI S, BORRACHI P, REITANO M et al. Growth fraction (Ki-67 antibody) determination in early-stage breast carcinoma: histologic, clinical, and prognostic correlations. The Breast 1992 ; 1 : 92-9.
36. SERON D, ALEXOPOULOS E, RAFTERY MJ, HARTLEY RB, CAMERON JS. Diagnosis of rejection in renal allograft biopsies using the presence of activated and proliferating cells. Transplantation 1989 ; 47 : 811-6.
37. BOUZUBAR N, WALKER K, GRIFFITHS K, ELLIS I, ELSTON C, ROBERTSON J et al. Ki67 immunostaining in primary breast cancer: pathological and clinical associations. Br J Cancer 1989 ; 59 : 943-7.
38. VIELH P, CHEVILLARD P, MOSSERI V, DONATINI B, MAGDELENAT H. Ki67 index and S-phase fraction in human breast carcinomas. AmJ Clin Pathol 1990 ; 94 : 681-6.
39. BEVILACQUA P, VERDERIO P, BARBARESCHI M, BONOLDI E, BORACCHI P, DALLA PALMA P et al. Lack of prognostic significance of the monoclonal antibody Ki-S1, a novel marker of proliferative activity, in node-negative breast carcinoma. Breast Cancer Res Treat 1996 ; 37 : 123-33.
40. KESHGEGIAN AA, CNAAN A. Proliferation markers in breast carcinoma. Mitotic figure count, S-phase fraction, proliferating cell nuclear antigen, Ki-67 and MIB 1. Am J Clin Pathol 1995 ; 104 : 42-9.
41. KUBOTA Y, PETRAS R, EASLEY K, BAUER T, TUBBS R, FAZIO V. Ki-67-determined growth fraction versus standard staging and grading parameters in colorectal carcinoma. Cancer 1992 ; 70 : 2602-9.
42. SADI M, BARRACK E. Determination of growth fraction in advanced prostate cancer by Ki-67 immunostaining and its relationship to the time to tumor progression after hormonal therapy. Cancer 1991 ; 67 : 3065-71.
43. JAROS E, PERRY R, ADAM L, KELLY P, CRAWFORD P, KALBAG R et al. Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours. Br J Cancer 1992 ; 66 : 373-85.
44. KAUDEWITZ P, BRAUN-FRANCO O, ERNST M, LANDTKALER M, STOLZ W, GERDES J. Tumor cell growth fractions in human malignant melanomas and the correlation to histopathologic tumor grading. Am J Pathol 1989 ; 134 : 1063-8.
45. UEDA T, OAZASA K, TSIJIMOTO M, OHSAWA M, UCHIDA A, AOKI Y et al. Prognostic significance of Ki-67 reactivity in soft tissue sarcomas. Cancer 1989 ; 63 : 1607-11.
46. PIERGA J-Y, LEROYER A, VIELH P, MOSSERI V, CHEVILLARD S, MAGDELÉNAT H. Long term prognostic value of growth fraction determination by Ki-67 immunostaining in primary operable breast cancer. Breast Cancer Res Treat 1996 ; 37 : 57-64.
47. GASPARINI G, BORACCHI P, VERDERIO P, BEVILACQUA P. Cell kinetics in human breast cancer: comparison between the prognostic value of the cytofluorimetric S-phase fraction and that of the antibodies to Ki-67 and PCNA antigens detected by immunocytochemistry. Int J Cancer 1994 ; 57 : 822-9.
48. GHNASSIA J. L'antigène nucléaire de prolifération cellulaire (PCNA). Ann Pathol 1996 ; 16 : 241-6
49. KAMEL O, FRANKLIN W, RINGUS J, MEYER J. Thymidine labelling index and Ki-67 growth fraction in lesions of the breast. Am J Pathol 1989 ; 134 : 107-13.
50. SASAKI K, MATSUMURA K, TSUJI T, SHINOZAKI F, TAKAHASHI M. Relationship between labelling indices of Ki-67 and BrdU in human malignant tumors. Cancer 1988 ; 62 : 989-93.
51. HARVEY JM, DE KLERK NH, ROBBINS PD, STERRETT GF. Histological grading of breast cancer: a study of reproducibility of consensus grading. The Breast 1995 ; 4 : 297-300.
52. VAN DIEST PJ, BAAK JPA, MATZE-COK P, WISSE-BREKELMANS ECM, VAN GALEN CM, KURVER PHJ et al. Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the multicenter morphometric mammary carcinoma project. Hum Pathol 1992 ; 23 : 603-7.
53. Treatment of early-stage breast cancer. NIH consensus conference. JAMA 1991 ; 265 : 391-5.
54. LINDEN MD, TORRES FX, KUBUS J, ZARBO RJ. Clinical application of morphologic and immunocytochemical assessments of cell proliferation. Am J Clin Pathol 1992 ; 97 : S4-S13.
55. SCHLÜTER C, DUCHROW M, WOHLENBERG C, BECKER MHG, KEY G, FLAD, HD et al. The cell proliferation-associated antigen of antibody Ki-67 : A very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J Cell Biol 1993 ; 123 : 513-22.
56. MEGGETTO F, AL SAATI T, COHEN-KNAFO E, ROUBINET F, SELVES J, BOUCHE G et al. Production of a monoclonal antibody (IND.64) identifying a cell cycle-associated antigen using spleen cells from nude mice bearing Ichikawa tumour. J Pathol 1992 ; 168 : 187-6.
57. KREIPE H, WACKER H, HEIDEBRECHT J, HAAS K, HAUBERG M, TIEMANN H, et al. Determination of the growth fraction in non-Hodgkin's lymphomas by monoclonal antibody Ki-S5 directed against a formalin-resistant epitope of the Ki-67 antigen. Am J Pathol 1993 ; 142 : 1689-94.